The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 701–800 of 1,810
Jiang, C., Wen, H., Hu, T., Liu, Y., Dai, X., & Chen, Y. (2024) · Health Science Reports · doi:10.1002/hsr2.1903 · Cited by 14
Expression and Regulation of Aquaporins in Pregnancy Complications and Reproductive Dysfunctions
Shao, H., Gao, S., Ying, X., Zhu, X., & Hua, Y. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5983 · Cited by 7
“GDM is defined as the onset or first recognized diabetes mellitus during pregnancy, characterized by insulin resistance and hyperinsulinism (Plows et al. , 2018).”
Environmental pollution and diabetes mellitus
Sikaily, A. E., & Helal, M. (2021) · World Journal of Meta-Analysis · doi:10.13105/wjma.v9.i3.234 · Cited by 8
Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers
Wang, Y., Song, M., & Qi, B. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1532 · Cited by 11
Baumgaertner, F., Ramírez-Zamudio, G. D., Menezes, A. C. B., Jurgens, I. M., Hirchert, M. R., Hurlbert, J. L., Bochantin-Winders, K. A., Diniz, W. J. S., Reynolds, L. P., Ward, A. K. K., et al. (2024) · Journal of Animal Science · doi:10.1093/jas/skae295 · Cited by 8
Alshganbee, M. F. H., Nabatchian, F., Farrokhi, V., Fadaei, R., Moradi, N., & Afrisham, R. (2023) · The Journal of Physiological Sciences · doi:10.1186/s12576-023-00879-z · Cited by 7
“Notably, changes in the levels of steroid hormones (e.g., cortisol, progesterone, estrogen) and placental hormones (e.g., placental lactogen hormone) can exacerbate insulin resistance [3, 7].”
BackgroundBasarab, M. R., Ivanko, K. O., & Kulkarni, V. V. (2021) · Microsystems Electronics and Acoustics · doi:10.20535/2523-4455.mea.228845 · Cited by 9
Chiu, H.-Y., Chen, H., Wang, C.-W., Lu, H., Wu, C.-H., Yang, C., Lee, S.-L., & Lai, J. C. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2024.01.039 · Cited by 13
Bai, Y., Du, Q., Zhang, L., Li, L., Tang, L., Zhang, W., Du, R., Li, P., & Li, L. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab033 · Cited by 7
Valerio, J., Barabash, A., de la Torre, N. G., de Miguel, P., Melero, V., del Valle, L., Moraga, I., Familiar, C., Durán, A., Torrejón, M. J., et al. (2022) · Nutrients · doi:10.3390/nu14224712 · Cited by 10
Freitas, R. G. B. D. O. N., Vasques, A. C. J., Fernandes, G. D. R., Ribeiro, F. B., Solar, I., Barbosa, M., de Almeida-Pititto, B., Geloneze, B., & Ferreira, S. R. G. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01182-7 · Cited by 7
Tossetta, G., Campagna, R., Vignini, A., Maruotti, G. M., Motta, M., Murolo, C., Sarno, L., Grelloni, C., Cecati, M., Giannubilo, S. R., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020919 · Cited by 10
“Placental balance, trophoblast activity, and fetal metabolic programming are affected by complex disruptions of metabolic pathways driven by elevated maternal glucose and insulin levels in GDM [62].”
Aguíñiga-Sánchez, I., Morales-Altamirano, A. M., Santiago-Osorio, E., Rosado-Pérez, J., Cadena-Íñiguez, J., Mendoza-Núñez, V. M., Weiss‐Steider, B., García-Gavia, G., Arista-Ugalde, T. L., Arreola-Gómez, N. A., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106499 · Cited by 7
Fuller, H., Iles, M. M., Moore, J. B., & Zulyniak, M. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1157416 · Cited by 8
“However, if gestational IR exceeds healthy levels and glycaemia is uncontrolled, moderate IR can progress to gestational diabetes mellitus (GDM) (1, 5).”
BackgroundSteroids, steroid associated substances and gestational diabetes mellitus
Hill, M., Pařízek, A., Šimják, P., Koucký, M., Anderlová, K., Krejčí, H., Vejražková, D., Ondřejíková, L., Černý, A., & Kancheva, R. L. (2021) · Physiological Research · doi:10.33549//physiolres.934794 · Cited by 34
Tagami, K., Iwama, N., Hamada, H., Tomita, H., Kudo, R., Kumagai, N., Wang, H., Izumi, S., Watanabe, Z., Ishikuro, M., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14159 · Cited by 7
Characterization of human placental fetal vessels in gestational diabetes mellitus
Carstens, P. S., Brendel, H., Ballesteros, M. L. V., Mittag, J., Hengst, C., Brunssen, C., Birdir, C., Taylor, P. D., Poston, L., & Morawietz, H. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03028-6 · Cited by 10
“This decreased insulin sensitivity during pregnancy affects the glucose transfer to the growing fetus [3].”
InfluentialPlacenta-Derived Exosomes and Gestational Diabetes Mellitus
Liu, X., & Qiu, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s363226 · Cited by 9
Kang, D. H., Kim, M. J., Mohamed, E. A., Kim, D. S., Jeong, J. S., Kim, S. Y., Kang, H., Lee, G., Hong, E., Ahn, C., et al. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad059 · Cited by 9
“In most cases, hyperglycemia results from impaired glucose tolerance due to pancreatic β-cell dysfunction and chronic insulin resistance [2].”
BackgroundDudzik, D., Atanasova, V. B., Barbas, C., & Bartha, J. L. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1452312 · Cited by 11
Chieu, R. V., Hamilton, K., Ryan, P. M., Copeland, J. K., Wang, P. W., Retnakaran, R. R., Guttman, D. S., Parkinson, J., & Hamilton, J. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356277 · Cited by 7
“12 13–15 16S rRNA gene surveys have shown that the gut microbiota of infants born to mothers with GDM exhibit a significant decrease in alpha diversity, 16,17 together with a loss in abundance of several taxa, including Lactobacillus and Flavonifractor .”
BackgroundDeischinger, C., Harreiter, J., Leitner, K., Wattar, L., Baumgartner-Parzer, S. M., & Kautzky‐Willer, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-03454-x · Cited by 7
Liang, Q., Li, M., Huang, G., Li, R., Qin, L., Zhong, P., Xing, X., & Yu, X. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae200 · Cited by 6
Hooks, S. K., Abiodun-Ojo, O. A., Noah, A. I., Hill, A. V., Perez-Patron, M. J., Menon, R., & Taylor, B. D. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01106-7 · Cited by 9
“Individuals who develop GDM already have evidence of metabolic dysfunction and inflammation before conception, such as pancreatic β-cell defects, dysfunctional neurohormonal networks, and increased insulin resistance [11].”
BackgroundCadmium exposure and the risk of GDM: evidence emerging from the systematic review and meta-analysis
Zhou, M., Peng, L., Wang, J., Cao, R., Ou, Z., & Fang, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-21171-4 · Cited by 8
“Insulin resistance results in a lifted level of blood glucose that further deteriorate pancreatic β cell function via glucose overload, forming a vicious circle in the etiology of GDM (Plows et al. 2018).”
BackgroundInfluentialPagotto, V., Posadas Martínez, M. L., Salzberg, S., & Pochettino, P. A. (2022) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v79.n3.36734 · Cited by 7
Biomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility
Pramodkumar, T. A., Hannah, W., Anjana, R. M., Ram, U., Tiwaskar, M., Gokulakrishnan, K., Popova, P. V., & Mohan, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0849 · Cited by 7
“27,73 This disruption of insulin pathways is a core feature of GDM and exacerbates glucose intolerance.”
Zhang, R., Gao, X., Sun, T., Li, H., Yang, Q., Li, B., Zhu, D., & Wang, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1054153 · Cited by 7
“The inclusion criteria were as follows: (1) aged 18–45 years; (2) gestational weeks 24–28; (3) confirmed GDM diagnosis with OGTT; (4) singleton pregnancy; (5) no preexisting health conditions such as diabetes, hypertension, or ischemic heart diseases; (6) currently living in Songjiang district of Shanghai; and (7) bei…”
BackgroundInfluentialStrobel, K. M., Kafalı, S. G., Shih, S., Artura, A. M., Masamed, R., Elashoff, D. A., Wu, H. H., & Calkins, K. L. (2022) · Journal of Perinatology · doi:10.1038/s41372-022-01549-5 · Cited by 9
“First, pregnancies complicated by GDM are hallmarked by an increase in placental glucose, amino acid, and fatty acid transport, which increases the fetus’s endogenous production of insulin and insulin-like growth factor 1 [35].”
BackgroundAbualsaud, R., Baghdadi, E., Bukhari, A. A., et al. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2485_21 · Cited by 7
“Gestational diabetes mellitus (GDM) is one of the common complications that affect the health of pregnant women and fetuses making pregnancy a high‐risk pregnancy.[1,2] GDM is a subtype of diabetes mellitus defined as glucose intolerance with onset or first recognition during pregnancy.”
BackgroundHan, L., Ma, J., Wang, S., & Li, Z. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.4.5090 · Cited by 7
High-Risk Pregnancies and Their Impact on Neonatal Primary Hemostasis
Politou, M., Mougiou, V., Kollia, M. E., Sokou, R., Kafalidis, G., Iliodromiti, Z., Valsami, S. I., Boutsikou, Τ., & Iacovidou, N. M. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-3400258 · Cited by 6
Hallig, S. J., Aalders, J., Christensen, M. H., Andersen, M., Vinter, C. A., Dunne, F., Højlund, K., Jensen, D. M., & Overgaard, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16148 · Cited by 6
Wilkof‐Segev, R., Hallak, M., & Gabbay‐Benziv, R. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0205 · Cited by 11
Lai, J. S., Godfrey, K. M., Ong, C. N., Tan, K. H., Yap, F. K. P., Chong, Y. S., Chan, J. K. Y., Chan, S., & Chong, M. F. (2023) · Nutrients · doi:10.3390/nu15204421 · Cited by 9
“Emerging evidence suggests that increased oxidative stress may be involved in the pathogenesis of gestational diabetes mellitus (GDM) [2].”
BackgroundLin, L., Xu, L., Dong, J.-Y., Song, L., Ye, X., Lin, J., & Miao, C. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112901 · Cited by 8
Gică, N., & Huluță, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002793 · Cited by 11
Jiang, L., & Li, A. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07733-6 · Cited by 6
Education programs for gestational diabetes mellitus: A systematic review
Akalpler, O., & Bağrıaçık, E. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200195 · Cited by 15
Genetics and epigenetics of diabetes and its complications in India
Priyadarshini, A., Madan, R., & Das, S. (2023) · Human Genetics · doi:10.1007/s00439-023-02616-3 · Cited by 9
“In GDM, spontaneous hyperglycemia develops in pregnant women without any prior history of diabetes (Plows et al. 2018).”
de Langarica, A. G. G., Hediger, H., Kaeppeli, B. M., & Keller‐Senn, A. (2022) · Midwifery · doi:10.1016/j.midw.2022.103367 · Cited by 14
Gerede, A., Domali, E., Chatzakis, C., Margioula‐Siarkou, C., Petousis, S., Stavros, S., Nikolettos, K., Gouveri, E., Sotiriou, S., Tsikouras, P. N., et al. (2025) · Life · doi:10.3390/life15010130 · Cited by 13
The advantages of Faecalibacterium prasnitzii in gestational diabetes mellitus
Safarzadeh, H., Aliramezani, A., Rahimi, A., Yousefi, B., & Heidarzadeh, S. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2520699 · Cited by 7
Li, H., An, J. R., Seo, M. S., Kang, M., Heo, R., Park, S., Mun, S., Bae, Y. M., Han, E., Han, J., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120169 · Cited by 8
Nakandakare, P. Y., Nicoletti, C. F., Noronha, N. Y., Nonino, C. B., Argentato, P. P., Dejani, N. N., Luzia, L. A., Rogero, M. M., & Rondó, P. H. D. C. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00857-8 · Cited by 10
Hu, T., An, Z., Li, H., Liu, Y.-P., Xia, L., Qiu, L., Yao, A., Ma, L., & Liu, L. (2022) · Disease Markers · doi:10.1155/2022/4231031 · Cited by 7
The human milk endocannabinoidome and neonatal growth in gestational diabetes
Fradet, A., Castonguay-Paradis, S., Dugas, C., Perron, J., St‐Arnaud, G., Marc, I., Doyen, A., Flamand, N., Dahhani, F., Marzo, V. D., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1415630 · Cited by 7
“Children exposed in utero to GDM are at risk of obesity and type 2 diabetes in adulthood (2, 3).”
BackgroundSkibińska, M., Kacerovský, M., Grzesiak, M., & Wujcicka, W. I. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1663643 · Cited by 7
Zhao, H., Chen, S., Lin, S., & Mei, X. (2024) · Regenerative Biomaterials · doi:10.1093/rb/rbae087 · Cited by 6
Fang, C., Wu, S., Zhang, J., Tian, Q., Zhang, Z., & Wu, L. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01209-0 · Cited by 8
Filippo, D. D., Bell, C., Chang, M. H. Y., Darling, J., Henry, A., & Welsh, A. W. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04629-8 · Cited by 6
“In GDM, an alteration of the insulin receptors combined with underlying subclinical factors (as metabolic syndrome/high BMI/PCOS) accentuates the insulin resistance, resulting in beta-cell dysfunction and maternal hyperglycaemia [21, 22].”
BackgroundFetal Growth Acceleration—Current Approach to the Big Baby Issue
Modzelewski, J., Kajdy, A., Muzyka-Placzyńska, K., Sys, D., & Rabijewski, M. (2021) · Medicina · doi:10.3390/medicina57030228 · Cited by 14
“In contrast, placental glucose uptake is increased [3].”
BackgroundAbbas, A. A., Almaghrbi, H., Giordo, R., Zayed, H., & Pintus, G. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110168 · Cited by 7
Luccisano, S. P., Weber, H. C., Murfet, G. O., Robertson, I. K., Prior, S. J., & Hills, A. P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212006 · Cited by 8
Khambule, L., Chikomba, C. E., Adam, Y., Khan, L., Haldane, C., Vetter, B., & George, J. A. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15914 · Cited by 7
Kyrkou, C., Athanasiadis, A. P., Chourdakis, M., Kada, S., Βiliaderis, C. G., Menexes, G. C., & Michaelidou, A.-M. (2024) · Nutrients · doi:10.3390/nu16213632 · Cited by 10
“Although it is a complex, multifactorial disorder [2,3], it is widely accepted that GDM is primarily triggered, in most cases, by pancreatic β -cell dysfunction in the presence of chronic insulin resistance [4,5].”
BackgroundVass, R. A., Mikó, É., Prémusz, V., Vari, S. G., Kovacs, K., Bódis, J., & Ertl, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010312 · Cited by 9
“Traditionally attributed to an imbalance between pregnancy-induced insulin resistance and β -cell compensatory capacity, GDM is now understood as a complex disorder involving immunological, metabolic, endocrine, and environmental interactions [3].”
Zhang, T., Jiang, W., Huang, Y., Wang, C., Cao, J., Qiu, W., Huang, R., Zhang, J., Ye, W., & Zhang, Q. (2025) · BMC Public Health · doi:10.1186/s12889-025-22913-y · Cited by 6
“The etiology of GDM is multifactorial, including genetic, physiological, and lifestyle factors [5–7].”
Role of ChREBP and SREBP-1c in gestational diabetes: two key players in glucose and lipid metabolism
Eroğlu, N., Yerlikaya, F. H., Onmaz, D. E., & Çolakoğlu, M. C. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01050-x · Cited by 7
“Also, altered expression levels of downstream regulators of insulin signaling such as GLUT-4, insulin receptor substrate (IRS)-1 have been reported in GDM [22].”
BackgroundPolymer nanocomposites in diabetes management: advances in biosensors and drug delivery systems
Sen, A. (2025) · Discover Materials · doi:10.1007/s43939-025-00210-0 · Cited by 10
Juber, N. F., Abdulle, A. M., AlJunaibi, A., Alnaeemi, A., Ahmad, A. S., Leinberger‐Jabari, A., Dhaheri, A. S. A., AlZaabi, E., Mezhal, F., Al‐Maskari, F., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610339 · Cited by 7
“GDM is a multifactorial disease in which genetic, epigenetic, and environmental factors contribute to its development [1].”
BackgroundResultInfluentialAbella, L., D’Adamo, E., Strozzi, M., Sánchez-de-Toledo, J., Pérez‐Cruz, M., Gómez, O., Abella, E., Cassinari, M., Guaschino, R., Mazzucco, L., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031028 · Cited by 6
“, adipose tissue, heart and skeletal muscle, liver, islets of Langerhans) [30], (ii) hyperglycemia can influence S100B release in the extracellular space, Figure 4.”
BackgroundInfluentialNunes, C. B., Borges, M. C., Freathy, R. M., Lawlor, D. A., Qvigstad, E., Evans, D. M., & Moen, G.-H. (2024) · Metabolites · doi:10.3390/metabo14090508 · Cited by 9
Musa, E., Salazar‐Petres, E., Vatish, M., Levitt, N. S., Sferruzzi-Perri, A. N., & Matjila, M. J. (2024) · Placenta · doi:10.1016/j.placenta.2024.05.138 · Cited by 9
Metabolomic profiles and microbiota of GDM offspring: The key for future perspective?
Dessì, A., Tognazzi, C., Bosco, A., Pintus, R., & Fanos, V. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.941800 · Cited by 7
“Indeed, data on the short and long-term impact on both the mother and the child are now numerous (2, 5).”
BackgroundZeng, Y., & Piao, Y. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2293-7983 · Cited by 5
“Chronic low-grade inflammation (LGI) is believed to play a piv - otal part in the pathogenesis of GDM, with inflammatory media - tors regarded as risk factors for GDM progression [11–14].”
BackgroundHashmi, I. A., Yazidi, B. A., & Omari, O. A. (2022) · Journal of Healthcare Quality Research · doi:10.1016/j.jhqr.2021.12.004 · Cited by 7
Probiotic therapy as a promising strategy for gestational diabetes mellitus management
Lemos, D. E. D. A., Alves, J. L. D. B., & de Souza, E. L. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2409880 · Cited by 8
“GDM is a clinical condition primarily characterized by insulin resistance and pancreatic β-cell dysfunction, causing persistent hyperglycemia during pregnancy [4].”
InfluentialDifferential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
Broberg, E., English, J., Clarke, D. M., Shin, M. J., Bikman, B. T., Reynolds, P. R., & Arroyo, J. A. (2025) · Cells · doi:10.3390/cells14060416 · Cited by 6
“…adverse outcomes such as an increased risk of hypertensive disorders and long-term metabolic conditions for both mother and child [3,4]. associated with various adverse outcomes such as an increased risk of hypertensive disorders and long-term metabolic conditions for both mother and child [3,4].”
InfluentialMaresh, M., Lawrence, J. M., Scholtens, D. M., Kuang, A., Lowe, L. P., Deerochanawong, C., Sacks, D. A., Lowe, W. L., Dyer, A. R., & Metzger, B. E. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00468-2 · Cited by 7
“, tumor necrosis factor-alpha, interleukin-6, and interleukin-1β), oxidative stress and, possibly, the gut microbiome (24).”
BackgroundAssociation between fetal fraction of cell-free DNA and adverse pregnancy outcomes
Gölbaşı, H., Bayraktar, B., Gölbaşı, C., Ömeroğlu, İ., Adıyaman, D., Alkan, K. O., Özdemir, T. R., Kaya, Ö. Ö., Özyılmaz, B., & Ekin, A. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07443-z · Cited by 9
“However, previous studies have shown that the increase in placental hormones (such as human placental lactogen, etc.) in GDM occurs at the end of the second trimester [34, 35].”
Lai, M., Li, J., Yang, J., Zhang, Q., Gong, Y., Ma, Y., Fang, F., Li, N., Zhai, Y., Shen, T., et al. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae010 · Cited by 6
“Taken together, these findings suggest that Cys reduces GDM-induced hepatic gluconeogenesis by inhibiting PCK, which is an important factor in the pathogenesis of GDM (Plows et al., 2018 ).”
BackgroundWaugh, C., Pencheva, N., Woolner, A., & Black, M. E. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.05.024 · Cited by 10
Paramasivam, S., Krishnaswamy, S., & Giles, M. (2023) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2023.1184090 · Cited by 7
“Furthermore, GDM predisposes women to an increased lifetime risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD); and via epigenetic modifications can expose babies of mothers with GDM to an increased risk of childhood obesity, T2DM, CVD and associated metabolic diseases (23).”
BackgroundInfluentialLi, F., Zhou, X., Cheng, D., Wang, H., & Xu, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s315422 · Cited by 8
“Increased glucose-stimulated insulin secretion and hypertrophy and hyperplasia of pancreatic β-cells tend to maintain glucose homeostasis and make up for these unfavorable changes.(12) Numerous studies have suggested that women who develop GDM have evidence of metabolic dysfunction before conception, including pancrea…”
BackgroundRole of low-dose cadmium exposure to the pathogenesis of gestational diabetes mellitus
Chen, H., Bin, J., Cao, Z., Luo, Y., Song, P., He, J., Lu, S., Mahai, G., Zheng, J.-Q., Li, Y., et al. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126718 · Cited by 8
Fecal Short-Chain Fatty Acids Are Associated with Obesity in Gestational Diabetes
Molan, K., Avguštin, J. A., Likar, M., Barlovič, D. P., Barlovič, D. P., & Erjavec, M. S. (2025) · Biomedicines · doi:10.3390/biomedicines13020387 · Cited by 8
“In the majority of GDM cases, the pancreatic β -cells are unable to compensate for the chronic excess fuel, which eventually leads to insulin resistance, hyperglycemia, and increased glucose supply to the growing fetus [30].”
Sex hormone-binding globulin is a valuable diagnostic indicator of gestational diabetes mellitus
Basil, B., Blessing, M.-M. K., Mba, I. N., Gbaa, T. T., & Dogoh, F. (2024) · Ghana Medical Journal · doi:10.4314/gmj.v58i1.8 · Cited by 7
“As such, we recommend further studies with larger sample sizes involving different African populations wherein OGTT and SHBG assay are carried into puerperium to assess post-delivery GDM.”
BackgroundMethodInfluentialTaye, H., Kabthymer, R. H., Hailu, S., Meshesha, M. D., Kanno, G. G., Bayisa, Y., & Molla, W. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2083399 · Cited by 8
Orenshtein, S., Sheiner, E., Kloog, I., & Wainstock, T. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101050 · Cited by 7
Zhang, H., Xia, Y., Zhang, X., Chang, Q., & Zhao, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.992472 · Cited by 6
“Gestational diabetes mellitus (GDM) is defined as chronic hyperglycemia during the gestational period in women without prior diabetes (1).”
BackgroundMaternal Chromium Levels in Gestational Diabetes: Systematic Review and Meta-Analysis
Sharma, A. K., Mohan, L., Mittal, S., Bahadur, A., Mirza, A. A., & Kumari, R. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_219_22 · Cited by 6
“[3] Increased IR increases circulating levels of glucose that can diffuse across placenta to the foetus.[3] IR gradually increases as pregnancy progresses from first to second and third trimester.”
BackgroundInfluentialKara, S. M. G., Bülbül, G. A., Kirtiş, E., Kandemir, H., Küçükçetin, İ. Ö., Özdem, S., Doğan, N. U., & Sanhal, C. Y. (2025) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2025.2491454 · Cited by 7
“The contributing elements to IR comprise placental hormones, inflammation, metabolic changes, genetics, the environment, and epigenetic modifications [16,17].”
Assessing risk factors that can cause overweight and obesity in women of reproductive age
Makarova, E. L., Olina, A. A., & Padrul, M. M. (2020) · Health Risk Analysis · doi:10.21668/health.risk/2020.2.04.eng · Cited by 10
Subarto, C. B., Matsuzaki, M., Estradé, M., Sundemeir, S., Hakimi, M., Isnaeni, Y., Hadi, H., Kurniasari, Y., Fatimah, S., Yulyani, L., et al. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9500 · Cited by 9
Jiang, W., Sun, X., Liu, F., Cheng, G., Li, S., Xu, M., Wu, Y., & Wang, L. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231160327 · Cited by 6
Cai, D., & Su, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30352 · Cited by 8
“Contents lists available at ScienceDirect pregnancy, with an incidence of about 5 % [1].”
BackgroundSheng, Y., Cun, D., Chen, Y., Hu, X.-J., Zhang, X., Sun, X., & Song, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01914-2 · Cited by 6
“GDM is regarded as a temporary manifestation of chronic metabolic dysfunction, with affected individuals frequently exhibiting ongoing disturbances in blood glucose and lipid metabolism even postpartum [26].”
Hassan, A. M. A., Alghamdi, G. S., Alfantoukh, A. M., Aljohani, A., Alzahrani, F. A., Eissa, G. A., Alkhedewi, L. A., Aloufi, L., Khawaji, O. A., & Khurmi, R. A. (2023) · Cureus · doi:10.7759/cureus.50458 · Cited by 6
Wang, J., Ji, X., Liu, T., & Zhao, N. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00925-7 · Cited by 8
“For a study to be eligible for inclusion, it should have been conducted in pregnant women with GDM and had compared outcomes of interest among those that were managed using neutral protamine Hagedron (NPH) and those managed with long-acting insulin analogues.”
BackgroundInfluentialDubois, N., & Giroux, I. (2025) · Healthcare · doi:10.3390/healthcare13182261 · Cited by 15
Guzylack‐Piriou, L., & Ménard, S. (2021) · Biomolecules · doi:10.3390/biom11050687 · Cited by 8
“GDM occurs when pregnant women are unable to balance the increased requirements of insulin [38].”
BackgroundChen, L., Zhang, W., Fu, A., Zhou, L., & Zhang, S. (2022) · PubMed · Cited by 8
Yong, H. E. J., Watkins, O. C., Mah, T. K. L., Cracknell-Hazra, V. K. B., Pillai, R. A., Selvam, P., Islam, M. O., Sharma, N., Cazenave‐Gassiot, A., Bendt, A. K., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1166827 · Cited by 7
“Thus, to determine whether such factors altered the relationships of CPT1B expression and maternal age with placental acylcarnitines, we examined these associations following stratification by BMI (Figure 3) and GDM status (Supplementary Figure S1).”
BackgroundInfluentialLiu, Q., Han, Y., Zhang, M., Yang, P., Xiang, Y., Chen, M., Xu, F., Zhou, X., Zheng, D., & Qin, J. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2023.100850 · Cited by 7
Tao, M., Lu, G., Zhang, S., & Pan, L. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117490 · Cited by 7
The predictive value of the first trimester combined test for gestational diabetes mellitus
Yildiz, A., Yozgat, S. T., Çökmez, H., & Yildiz, F. Ş. (2022) · Ginekologia Polska · doi:10.5603/gp.a2022.0036 · Cited by 7
“Hyperglycemia that is diagnosed for the first time during pregnancy and is confirmed by appropriate laboratory tests is called gestational diabetes mellitus (GDM) [1].”
BackgroundLin, H., Chen, X., Wang, L., Zhu, T., Feng, X., Liu, X., Chen, H., & Pan, S. Y. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07518-x · Cited by 9
“One reason is that the molecular mechanisms of GDM are still unclear [1].”
BackgroundSalahi, P., Rocky, A., Dezfoulian, O., Azizi, A., & Alirezaei, M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00572-7 · Cited by 6
“In this regard, sustaining balanced energymetabolism as the most decisive point to reach a normal pregnancy is crucially required [5, 31, 47].”
BackgroundConstruction and validation of risk prediction model for gestational diabetes based on a nomogram.
Li, R., Yuan, K., Yu, X., Jiang, Y., Liu, P., & Zhang, K. (2023) · PubMed Central · Cited by 10
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.